New tool aims to give voice to heart sarcoidosis patients
NCT ID NCT05145023
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to create and test a new questionnaire called CARD-SARC that measures how cardiac sarcoidosis affects patients' daily lives and well-being. Researchers worked with 130 adults diagnosed with cardiac sarcoidosis at two NHS specialist centres. The goal was to develop a reliable tool that doctors can use to track changes in quality of life over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SARCOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Papworth Hospital NHS Foundation Trust
Cambridge, CB20AY, United Kingdom
-
St Bartholomew's Hospital - Barts Health NHS Trust
London, EC1A 7DN, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Major study aims to uncover hidden heart disease and test steroid treatment
- New PET tracer aims to reveal hidden immune activity in tumors and arteries
- Could a simple blood test replace heart scans for sarcoidosis?
- Simple cheek swab could predict sudden cardiac death risk
- New scan could spot hidden heart inflammation early
- New combo therapy aims to tame heart sarcoidosis with fewer side effects